Fremanezumab migraine drug

Numéro d’image : 13511525
Fremanezumab migraine drug
MODEL RELEASED. Packaging for a pre-filled pen for injecting the migraine drug fremanezumab, marketed as Ajovy. This is a preventative treatment that is injected once a month. It is a humanised monoclonal antibody that blocks the calcitonin gene-related peptide receptor (CGRPR). Calcitonin gene-related peptide (CGRP) is a small protein that is released as a result of brain changes during migraine. Binding of CGRP to its receptor causes vasodilation (the widening of blood vessels) in the brain, which leads to headache. Fremanezumab was approved for treatment in the UK in 2020.
Licence : Droits gérés
Crédit: Science Photo Library / Marazzi, Dr. P.
Taille de l’image : 6048 px × 4024 px
Model Release : Disponible
Property Release : Non requis
Restrictions :
  • Editorial use only

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;